Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
CEVA Inc
CEVA
$910M
| $1.01M | ﹤0.01% |
41,900
+33,346
| +390% | +$724K |
|
3277
Pacific Biosciences
PACB
$435M
| $1.01M | ﹤0.01% |
595,150
+350,196
| +143% | +$575K |
|
3278
XPeng
XPEV
$12.4B
| $1.01M | ﹤0.01% |
82,920
-154,805
| -65% | -$1.28M |
|
3279
Axogen
AXGN
$2.27B
| $1.01M | ﹤0.01% |
72,036
+39,182
| +119% | +$433K |
|
3280
Zumiez
ZUMZ
$332M
| $1.01M | ﹤0.01% |
47,387
+16,934
| +56% | +$405K |
|
|
GOOD
3281
Gladstone Commercial Corp
GOOD
$605M
| $1.01M | ﹤0.01% |
62,132
+47,456
| +323% | +$712K |
|
3282
Insteel Industries
IIIN
$593M
| $1.01M | ﹤0.01% |
32,391
+25,405
| +364% | +$812K |
|
3283
CALL
GlobalFoundries
GFS
$27.4B
| $1.01M | ﹤0.01% |
+25,000
| New | +$1.16M |
|
3284
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.4B
| $1.01M | ﹤0.01% |
+9,988
| New | +$1M |
|
|
MTAL
3285
DELISTED
Metals Acquisition
MTAL
| $1M | ﹤0.01% |
72,260
+53,567
| +287% | +$661K |
|
3286
Liquidia Corp
LQDA
$7.48B
| $1,000K | ﹤0.01% |
99,984
+72,591
| +265% | +$793K |
|
3287
Vanguard FTSE Pacific ETF
VPL
$8.08B
| $992K | ﹤0.01% |
+12,661
| New | +$958K |
|
3288
CALL
Align Technology
ALGN
$12.1B
| $992K | ﹤0.01% |
3,900
-16,700
| -81% | -$3.94M |
|
|
HSHP
3289
Himalaya Shipping
HSHP
$741M
| $987K | ﹤0.01% |
114,004
+67,149
| +143% | +$533K |
|
3290
Petco
WOOF
$797M
| $985K | ﹤0.01% |
216,564
-255,201
| -54% | -$866K |
|
3291
Nordic American Tanker
NAT
$1.38B
| $984K | ﹤0.01% |
268,115
+196,571
| +275% | +$722K |
|
|
OKYO
3292
OKYO Pharma
OKYO
$88.2M
| $980K | ﹤0.01% |
961,000
| – | – |
|
3293
Stoke Therapeutics
STOK
$1.8B
| $980K | ﹤0.01% |
79,740
+47,239
| +145% | +$669K |
|
3294
PUT
Warby Parker
WRBY
$3.28B
| $980K | ﹤0.01% |
+60,000
| New | +$903K |
|
3295
Savara
SVRA
$1.12B
| $979K | ﹤0.01% |
231,005
+163,044
| +240% | +$720K |
|
3296
SGHC Ltd
SGHC
$7.11B
| $978K | ﹤0.01% |
269,435
+157,693
| +141% | +$544K |
|
3297
Tactile Systems Technology
TCMD
$635M
| $977K | ﹤0.01% |
66,885
+24,188
| +57% | +$313K |
|
3298
ArriVent BioPharma
AVBP
$1.39B
| $976K | ﹤0.01% |
41,522
+38,132
| +1,125% | +$866K |
|
3299
Tredegar Corp
TG
$265M
| $976K | ﹤0.01% |
133,827
+26,757
| +25% | +$156K |
|
3300
GoodRx Holdings
GDRX
$1.04B
| $972K | ﹤0.01% |
140,113
+130,219
| +1,316% | +$1.02M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.